Skip to main content

OSA - Obstructive Sleep Apnea

0
Pipeline Programs
2
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Sciwind Biosciences
Sciwind BiosciencesChina - Hangzhou
2 programs
XW003 injectionPHASE_31 trial
XW003 injectionPHASE_31 trial
Active Trials
NCT07387094Recruiting140Est. Dec 2027
NCT07434050Recruiting140Est. Jun 2028
ResMed
ResMedSAN DIEGO, CA
1 program
Positive Airway PressureN/A1 trial
Active Trials
NCT07420140Not Yet Recruiting15Est. Jun 2026

Trial Timeline

Clinical trial activity over time

2026
2027
2028
Sciwind BiosciencesXW003 injection
Sciwind BiosciencesXW003 injection
ResMedPositive Airway Pressure

Clinical Trials (3)

Total enrollment: 295 patients across 3 trials

NCT07434050Sciwind BiosciencesXW003 injection

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

Start: Mar 2026Est. completion: Jun 2028140 patients
Phase 3Recruiting
NCT07387094Sciwind BiosciencesXW003 injection

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

Start: Feb 2026Est. completion: Dec 2027140 patients
Phase 3Recruiting
NCT07420140ResMedPositive Airway Pressure

Evaluation of a Wearable PAP Device in a Tethered Configuration for the Treatment of Obstructive Sleep Apnoea.

Start: Mar 2026Est. completion: Jun 202615 patients
N/ANot Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 295 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.